Health Care & Life Sciences » Pharmaceuticals | YungShin Global Holding Corp.

YungShin Global Holding Corp. | Income Statement

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,062
5,827
6,034
6,191
6,623
7,514
Cost of Goods Sold (COGS) incl. D&A
2,838
3,230
3,393
3,677
3,983
4,161
Gross Income
2,224
2,597
2,641
2,514
2,639
3,353
SG&A Expense
1,615
1,778
1,800
1,987
2,117
2,551
EBIT
609
819
841
-
523
802
Unusual Expense
-
70
67
39
-
3
Non Operating Income/Expense
99
120
89
216
66
82
Interest Expense
20
19
23
40
51
62
Pretax Income
693
859
986
670
540
823
Income Tax
136
204
216
152
154
248
Equity in Affiliates
62
74
125
91
81
110
Consolidated Net Income
619
728
895
609
468
685
Net Income
619
720
893
658
514
702
Net Income After Extraordinaries
619
720
893
658
514
702
Net Income Available to Common
619
720
893
658
514
702
EPS (Basic)
2.32
2.70
3.35
2.47
1.93
2.64
Basic Shares Outstanding
266
266
266
266
266
266
EPS (Diluted)
2.32
2.70
3.35
2.47
1.93
2.63
Diluted Shares Outstanding
266
266
266
266
266
266
EBITDA
982
1,138
1,158
856
854
1,157
Non-Operating Interest Income
5
9
11
5
3
3
Minority Interest Expense
-
8
2
49
46
17

About YungShin Global Holding

View Profile
Address
25th Floor-1, 402 Shizheng Road
Taichung TX 407 57
Taiwan
Employees -
Website http://www.yungshingroup.com
Updated 07/08/2019
YungShin Global Holding Corp. engages in resources integration and business development. Its business scopes include research, development, and manufacture of pharmaceutical products (generic and branded drugs), active pharmaceutical ingredients; and healthcare and beauty care products. The company was founded on January 3, 2011 and is headquartered in Taichung, Taiwan.